Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
about
Elusive roles for reactive astrocytes in neurodegenerative diseasesThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentRecent advances in quantitative neuroproteomicsProteomics of protein post-translational modifications implicated in neurodegenerationSex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusionProteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures.The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesisInterleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cellsCharacterization of murine brain membrane glycoproteins by detergent assisted lectin affinity chromatography.Calcineurin and glial signaling: neuroinflammation and beyondThe hippocampal neuroproteome with aging and cognitive decline: past progress and future directions.Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.The small chaperone protein p23 and its cleaved product p19 in cellular stress.Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterationsGlycoproteomic analysis of the secretome of human endothelial cellsImpairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.Lectin-affinity chromatography brain glycoproteomics and Alzheimer disease: insights into protein alterations consistent with the pathology and progression of this dementing disorder.The neuropathological profile of mild cognitive impairment (MCI): a systematic review.α-Enolase, a multifunctional protein: its role on pathophysiological situationsActin regulation by tropomodulin and tropomyosin in neuronal morphogenesis and function.Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of ageCharacterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein.Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease.Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission.Oleanolic Acid Inhibiting the Differentiation of Neural Stem Cells into Astrocyte by Down-Regulating JAK/STAT Signaling Pathway.Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.HNK-1 Carrier Glycoproteins Are Decreased in the Alzheimer's Disease Brain.Concanavalin agglutinin levels are decreased in peripheral blood of Alzheimer's disease patients.Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice.
P2860
Q26797399-32BDCCCE-0335-47C2-8661-F56B54A152BDQ26827320-421366B8-BEB3-42C1-8D09-39BE464BDEABQ27000073-B71E4BDA-D171-4DFB-8B9D-6735F2CBED71Q28088631-1049047E-9C7B-48BE-A48A-02095415BC2AQ28383413-4C0F3F25-C436-44CC-9C5B-4924B1D3EB64Q33720580-84B2E05A-56CB-451A-95C5-4F0D2CFC4172Q33737263-2D41EF56-7CF1-469E-BC8F-536A639C074EQ33906596-2F18FCE3-4CDB-4425-A58D-291F04996D4EQ34014666-7EC35EE6-3C86-4B98-9EB3-59BD90FAE671Q34092099-D4E522B5-7B19-40D0-8BB8-33BE1C63CA27Q34234080-4E898C5B-2ED0-4555-AB8D-BE91626AB0BCQ35007780-EF36AA25-5B46-4355-933E-C573902903B8Q35059268-2088E2A0-BBA3-4372-A26E-139AA4834576Q35633977-AFD33D79-2C47-4431-8120-52F4866ACA74Q36597843-290F2E05-C960-4B9C-A57A-75F8EA16F89DQ36742432-BC5E93F2-E68F-478A-895A-D23E1F31EBC7Q37613081-E0FF203D-5E9A-4DD9-B5B5-839548E6FD51Q37832686-86D68168-B440-4070-9140-D9C1FE019EE5Q37833589-D653C6AD-00CE-47D4-9E12-E04F36784DEDQ37964897-3DF2679E-6F28-48AE-8814-F357E9A0533EQ38057216-9C4B8A74-1D46-4707-BA90-7650BB35AB48Q38692012-E47EBF5E-893F-4056-B770-D7D79A215F23Q38793564-69B85387-8E48-4217-B3F6-6975EBE8B2FCQ41444056-1454FE26-3BAC-429B-A19C-484BF2CF3C0BQ42099415-3473351B-DD2F-438B-9F69-258213C84ABBQ42352469-32CA6004-D78F-471C-81A7-32117EFAC161Q47219270-7938216E-DFF0-4FDE-8E0B-22A687BD891FQ48062902-B492C85A-AE04-45AA-9557-6B8C02DCD27FQ48604859-BE5C9192-883F-46CC-97EA-7DAD7EDD7762Q49034569-09C110CD-BDC6-413D-878F-CC0898509079Q50435913-8E98995C-06ED-4A78-84DB-577E5EE3D87DQ55366391-90A926A6-ACB7-441A-A212-1163FBA348ED
P2860
Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteomics-determined differen ...... cations for progression of AD.
@en
Proteomics-determined differen ...... cations for progression of AD.
@nl
type
label
Proteomics-determined differen ...... cations for progression of AD.
@en
Proteomics-determined differen ...... cations for progression of AD.
@nl
prefLabel
Proteomics-determined differen ...... cations for progression of AD.
@en
Proteomics-determined differen ...... cations for progression of AD.
@nl
P2093
P2860
P356
P1476
Proteomics-determined differen ...... cations for progression of AD.
@en
P2093
Chiara Cini
Fabio Di Domenico
Joshua B Owen
Marzia Perluigi
Rukhsana Sultana
William M Pierce
P2860
P304
P356
10.1021/PR800667A
P577
2009-02-01T00:00:00Z